 For the evaluation of efficacy, the Patient Global Assessment, NYHA classification, KCCQ, 6-minute walk test, and efficacy-related clinical laboratory tests serum levels of troponin T, troponin I, and NT-pro-BNP will be determined every 6 months. In addition, echocardiograms will be performed every 12 months on an annual basis. 